P. Hans Hull's Insider Trades & SAST Disclosures
P. Hans Hull's most recent trade in Pliant Therapeutics Inc was a trade of 80,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern P. Hans Hull.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 80,300 | 80,300 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 40,150 | 251,708 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 15,936 | 211,558 | - | 11.2 | 178,501 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.56 per share. | 10 Jul 2024 | 9,900 | 227,494 | - | 11.6 | 114,444 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 19,337 | 237,394 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | P. Hans Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Hans Hull P. | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 31,500 | 216,569 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Hans Hull P. | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.23 per share. | 17 Jan 2024 | 9,786 | 185,069 | - | 17.2 | 168,613 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 03 Aug 2023 | 20,050 | 194,855 | - | 20.0 | 401,201 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 03 Aug 2023 | 13,069 | 206,114 | - | 20 | 261,380 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 8,791 | 31,367 | - | - | Common Stock (Right to Buy) | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 03 Aug 2023 | 8,791 | 214,905 | - | 2.1 | 18,285 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 1,800 | 40,158 | - | - | Common Stock (Right to Buy) | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 03 Aug 2023 | 1,800 | 206,114 | - | 20 | 36,000 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 03 Aug 2023 | 1,800 | 207,914 | - | 2.1 | 3,744 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Jul 2023 | 17,937 | 219,183 | - | 18.0 | 323,029 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 35,156 | 237,120 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 30 Mar 2023 | 9,036 | 201,964 | - | 26.5 | 239,643 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 17,578 | 211,000 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 76,200 | 76,200 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 54,000 | 192,191 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges